✨ Medicines and Tax Notices




4 OCTOBER 2007 NEW ZEALAND GAZETTE, No. 108

Schedule

Product: BeneFIX
Active Ingredient: Nonacog alfa 2,000IU
Dosage Form: Powder for injection
Diluent
New Zealand Sponsor: Wyeth (NZ) Limited
Manufacturer: Wyeth Farma S.A., Ctra de Madrid-Burgos, San Sebastian de los Reyes, Madrid, Spain

Product: Cetirizine Syrup
Active Ingredient: Cetirizine hydrochloride 1mg/mL
Dosage Form: Oral solution
New Zealand Sponsor: REX Medical Limited
Manufacturer: Mediorals Laboratories Pvt Limited, Satara, Maharashtra, India

Product: Lamivudine
Active Ingredient: Lamivudine 150mg
Dosage Form: Film coated tablet
New Zealand Sponsor: REX Medical Limited
Manufacturer: Cipla Limited, Verna Industrial Area, Salcette, Goa, India

Product: Mitozantrone Ebewe
Active Ingredient: Mitoxantrone hydrochloride 2.3284mg/mL equivalent to mitoxantrone 2mg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Pharmaco (NZ) Limited
Manufacturer: EBEWE Pharma GmbH Nfg KG, Unterach am Attersee, Austria

Product: Vicks Cough Lozenge with Honey for Dry Cough
Active Ingredient: Dextromethorphan 7.34mg
Dosage Form: Lozenge
New Zealand Sponsor: Procter & Gamble Distributing New Zealand
Manufacturer: Procter & Gamble GmbH, Gross Gerau, Germany

Product: Zobacin
Active Ingredients: Piperacillin sodium 2.085g equivalent to 2.000g piperacillin
Tazobactam sodium 268.3mg equivalent to 250mg tazobactam
Dosage Form: Powder for injection
New Zealand Sponsor: Pacific Pharmaceuticals Limited
Manufacturer: Laboratorio Farmaceutico CT SrL, San Remo (IM), Italy

Product: Zobacin
Active Ingredients: Piperacillin sodium 4.170g equivalent to 4.000g piperacillin
Tazobactam sodium 536.6mg equivalent to 500mg tazobactam
Dosage Form: Powder for injection
New Zealand Sponsor: Pacific Pharmaceuticals Limited
Manufacturer: Laboratorio Farmaceutico CT SrL, San Remo (IM), Italy

Dated this 27th day of September 2007.

JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate (pursuant to delegation given by the Minister of Health on 6 July 2001).

go6822

Inland Revenue

Income Tax Act 2004

Resident Withholding Tax on Interest
Reissued certificates of exemption for the period
01/07/2007 to 30/09/2007

10142792 10603587 10623731 10698294 10864879
10992486 11061325 11113338 11192688 11713114
11760775 11920675 12647565 13065365 13134413
13467854 13769508 13995540 14674225 17189034
17996866 20384298 21076147 22043846 23139537
24195228 24265269 24389049 24860388 26716446
26953197 27281192 27750591 27930638 27950833
29819548 32606008 33340328 35620468 35921923
36332316 38621629 38788477 38960894 39141868
41403119 42568503 42790605 43781170 44206481
46220781 46572025 46764935 46806387 47380669
49096070 49286975 50023494 50478068 50619885
51090225 51555473 51834097 52094429 52317320
52955343 53555349 55098409 55164916 55381585



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2007, No 108


Gazette.govt.nz PDF NZ Gazette 2007, No 108





✨ LLM interpretation of page content

πŸ₯ Consent to the Distribution of New Medicines (continued from previous page)

πŸ₯ Health & Social Welfare
27 September 2007
Medicines Act, New Medicines, Pharmaceutical Products
  • JOHN HAZELDINE, Acting Deputy Director-General, Sector Accountability and Funding Directorate

πŸ’° Resident Withholding Tax on Interest

πŸ’° Finance & Revenue
Income Tax Act, Tax Exemption, Certificates